Regulatory Case Study: The Role of Clinical Biomarkers in the Development of Gene Therapies
Time: 11:30 am
day: Day 1 - Regulatory 2
Details:
• Biomarkers relevant to disease progression that support differentiation of gene therapies
• Biomarkers as key end points for accelerated approval of gene therapies
• Innovative approaches in biomarker discovery for gene therapies
